Celldex Therapeutics, Inc. (Nasdaq: CLDX) 53.1% LOWER; announced that the independent Data Safety and Monitoring Board (DSMB) has determined, based ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Compass Point Cuts Price Target on Fortress Investment Group (FIG) to $6.50 March 9, 2016 8:16 AM Wedbush Remains Bullish Following Del Taco Restaurants' (TACO) 4Q and Guidance March 8, 2016 7:52 AM